What question did this study set out to answer?

To explore the epidemiology of Progressive Supranuclear Palsy (PSP) in Navarre, Spain, using the new MDS diagnostic criteria.

April 4, 2026Open Access

Epidemiology of Progressive Supranuclear Palsy in Navarre, Spain: A Population‐Based Study

Key Points

To explore the epidemiology of Progressive Supranuclear Palsy (PSP) in Navarre, Spain, using the new MDS diagnostic criteria.
Conducted a population-based epidemiological study.
Applied new MDS diagnostic criteria for PSP.
Collected data on incidence, prevalence, and mortality.
Established baseline incidence rates for PSP in the Navarre population.
Identified prevalence rates consistent with other European studies.
Highlighted mortality data related to PSP.

Abstract

This study represents the first population-based epidemiological study of PSP in Spain and the first with application of the new MDS diagnostic criteria in Europe, providing detailed incidence, prevalence, and mortality data that are in accordance with other European studies.

Read Full Paperexternally

Perguntar à IA

Bookmark

View Full Paper